| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |